Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro Pinto

Showing results (221-230 of 239) with videos related to

Pageof 24
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 12, 2021
Tracking SARS-CoV-2 lineage B.1.1.7 dissemination: insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data, Portugal, week 49 2020 to week 3 2021Vítor Borges, Carlos Sousa, Luís Menezes, et al.
Genes, Chromosomes & Cancer|April 11, 2019
The nonsense mutation MSH2 c.2152C>T shows a founder effect in Portuguese Lynch syndrome familiesManuela Pinheiro, Inês Francisco, Carla Pinto, et al.
Influenza and Other Respiratory Viruses|March 20, 2023
Comparative complete scheme and booster effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infections with SARS-CoV-2 Omicron (BA.1) and Delta (B.1.617.2) variants: A case-case study based on electronic health recordsIrina Kislaya, André Peralta-Santos, Vítor Borges, et al.
Emerging Infectious Diseases|February 3, 2023
Comparative Effectiveness of COVID-19 Vaccines in Preventing Infections and Disease Progression from SARS-CoV-2 Omicron BA.5 and BA.2, PortugalIrina Kislaya, Pedro Casaca, Vítor Borges, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 3, 2022
Ongoing monkeypox virus outbreak, Portugal, 29 April to 23 May 2022Mariana Perez Duque, Sofia Ribeiro, João Vieira Martins, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 8, 2024
Sharp increase in gonorrhoea notifications among young people, EU/EEA, July 2022 to June 2023Lina Nerlander, Lydia Champezou, Joana Gomes Dias, et al.
European Journal of Heart Failure|September 29, 2025
Blood pressure, safety and clinical efficacy of vericiguat in chronic heart failure with reduced ejection fraction: Insights from the VICTOR trialRobert J Mentz, Javed Butler, Ciaran J McMullan, et al.
Annals of Surgical Oncology|April 13, 2026
Consensus Guidelines on Perioperative Care in Primary Retroperitoneal Sarcoma SurgeryPablo Lozano Lominchar, Óscar Díaz-Cambronero, Paula Muñoz-Muñoz, et al.
Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology|February 28, 2025
Portuguese National Registry of Interventional Cardiology: Official report of percutaneous coronary angiography and intervention from 2014 to 2023Rita Calé, Hélder Pereira, André Luz, et al.
Lancet (London, England)|September 2, 2025
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trialJaved Butler, Ciaran J McMullan, Kevin J Anstrom, et al.
Pageof 24

Showing results (221-230 of 239) with videos related to

Sort By:
Pageof 24
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 12, 2021
Tracking SARS-CoV-2 lineage B.1.1.7 dissemination: insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data, Portugal, week 49 2020 to week 3 2021Vítor Borges, Carlos Sousa, Luís Menezes, et al.
Genes, Chromosomes & Cancer|April 11, 2019
The nonsense mutation MSH2 c.2152C>T shows a founder effect in Portuguese Lynch syndrome familiesManuela Pinheiro, Inês Francisco, Carla Pinto, et al.
Influenza and Other Respiratory Viruses|March 20, 2023
Comparative complete scheme and booster effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infections with SARS-CoV-2 Omicron (BA.1) and Delta (B.1.617.2) variants: A case-case study based on electronic health recordsIrina Kislaya, André Peralta-Santos, Vítor Borges, et al.
Emerging Infectious Diseases|February 3, 2023
Comparative Effectiveness of COVID-19 Vaccines in Preventing Infections and Disease Progression from SARS-CoV-2 Omicron BA.5 and BA.2, PortugalIrina Kislaya, Pedro Casaca, Vítor Borges, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 3, 2022
Ongoing monkeypox virus outbreak, Portugal, 29 April to 23 May 2022Mariana Perez Duque, Sofia Ribeiro, João Vieira Martins, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 8, 2024
Sharp increase in gonorrhoea notifications among young people, EU/EEA, July 2022 to June 2023Lina Nerlander, Lydia Champezou, Joana Gomes Dias, et al.
European Journal of Heart Failure|September 29, 2025
Blood pressure, safety and clinical efficacy of vericiguat in chronic heart failure with reduced ejection fraction: Insights from the VICTOR trialRobert J Mentz, Javed Butler, Ciaran J McMullan, et al.
Annals of Surgical Oncology|April 13, 2026
Consensus Guidelines on Perioperative Care in Primary Retroperitoneal Sarcoma SurgeryPablo Lozano Lominchar, Óscar Díaz-Cambronero, Paula Muñoz-Muñoz, et al.
Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology|February 28, 2025
Portuguese National Registry of Interventional Cardiology: Official report of percutaneous coronary angiography and intervention from 2014 to 2023Rita Calé, Hélder Pereira, André Luz, et al.
Lancet (London, England)|September 2, 2025
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trialJaved Butler, Ciaran J McMullan, Kevin J Anstrom, et al.
Pageof 24